This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

25 Oct 2012

Charles River enters strategic partnership with AstraZeneca

Charles River Laboratories and AstraZeneca have reached a three-year agreement to deliver toxicology, safety pharmacology and development DMPK studies.


Charles River Laboratories has entered into a strategic partnership with AstraZeneca for outsourced regulated safety assessment and development drug metabolism and pharmacokinetics (DMPK).

Related News